| Style | Citing Format |
|---|---|
| MLA | Fekrazad S, et al.. "Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue." Discover Oncology, vol. 17, no. 1, 2026, pp. -. |
| APA | Fekrazad S, Kazemian A, Shojaei S, Mousavi A, Aghaei MM, Shirkhoda M, Babaei M, Heidari F, Saeedi N, Aghili M, Amini A, Zakeri K, Ghalehtaki R (2026). Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue. Discover Oncology, 17(1), -. |
| Chicago | Fekrazad S, Kazemian A, Shojaei S, Mousavi A, Aghaei MM, Shirkhoda M, Babaei M, et al.. "Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue." Discover Oncology 17, no. 1 (2026): -. |
| Harvard | Fekrazad S et al. (2026) 'Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue', Discover Oncology, 17(1), pp. -. |
| Vancouver | Fekrazad S, Kazemian A, Shojaei S, Mousavi A, Aghaei MM, Shirkhoda M, et al.. Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue. Discover Oncology. 2026;17(1):-. |
| BibTex | @article{ author = {Fekrazad S and Kazemian A and Shojaei S and Mousavi A and Aghaei MM and Shirkhoda M and Babaei M and Heidari F and Saeedi N and Aghili M and Amini A and Zakeri K and Ghalehtaki R}, title = {Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue}, journal = {Discover Oncology}, volume = {17}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Fekrazad S AU - Kazemian A AU - Shojaei S AU - Mousavi A AU - Aghaei MM AU - Shirkhoda M AU - Babaei M AU - Heidari F AU - Saeedi N AU - Aghili M AU - Amini A AU - Zakeri K AU - Ghalehtaki R TI - Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue JO - Discover Oncology VL - 17 IS - 1 SP - EP - PY - 2026 ER - |